This page has not been authorized, sponsored, or otherwise approved or endorsed by the companies represented herein. Each of the company logos represented herein are trademarks of Microsoft Corporation; Dow Jones & Company; Nasdaq, Inc.; Forbes Media, LLC; Investor's Business Daily, Inc.; and Morningstar, Inc.
Copyright 2024 Zacks Investment Research | 10 S Riverside Plaza Suite #1600 | Chicago, IL 60606
At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1988 it has more than doubled the S&P 500 with an average gain of +24.03% per year. These returns cover a period from January 1, 1988 through July 1, 2024. Zacks Rank stock-rating system returns are computed monthly based on the beginning of the month and end of the month Zacks Rank stock prices plus any dividends received during that particular month. A simple, equally-weighted average return of all Zacks Rank stocks is calculated to determine the monthly return. The monthly returns are then compounded to arrive at the annual return. Only Zacks Rank stocks included in Zacks hypothetical portfolios at the beginning of each month are included in the return calculations. Zacks Ranks stocks can, and often do, change throughout the month. Certain Zacks Rank stocks for which no month-end price was available, pricing information was not collected, or for certain other reasons have been excluded from these return calculations. Zacks may license the Zacks Mutual Fund rating provided herein to third parties, including but not limited to the issuer.
Visit Performance Disclosure for information about the performance numbers displayed above.
Visit www.zacksdata.com to get our data and content for your mobile app or website.
Real time prices by BATS. Delayed quotes by Sungard.
NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least 15 minutes delayed.
This site is protected by reCAPTCHA and the Google Privacy Policy, DMCA Policy and Terms of Service apply.
View All Zacks #1 Ranked Stocks
Zacks News
Here's Why Investors Should Hold Acadia (ACHC) Stock for Now
by Zacks Equity Research
Acadia Healthcare (ACHC) remains well-poised for growth on the back of the solid demand for behavioral healthcare services, continuous pursuit of expansion initiatives and a notable financial position.
Here's Why HCA Healthcare (HCA) is a Strong Value Stock
by Zacks Equity Research
The Zacks Style Scores offers investors a way to easily find top-rated stocks based on their investing style. Here's why you should take advantage.
If You Invested $1000 in HCA Healthcare a Decade Ago, This is How Much It'd Be Worth Now
by Zacks Equity Research
Investing in certain stocks can pay off in the long run, especially if you hold on for a decade or more.
Zacks.com featured highlights include HCA Healthcare, Hubbell, Popular and Lennox International
by Zacks Equity Research
HCA Healthcare, Hubbell, Popular and Lennox International are part of the Zacks Screen of the Week article.
4 GARP Stocks to Scoop up for Maximum Returns
by Zacks Equity Research
Try the GARP strategy when seeking a profitable portfolio of stocks offering optimum value and growth investing. HCA, HUBB, BPOP and LII are some stocks that hold promise.
How to Find Strong Buy Medical Stocks Using the Zacks Rank
by Zacks Equity Research
Finding strong, market-beating stocks with a positive earnings outlook becomes easier with the Zacks Rank.
Pediatrix (MD) Q2 Earnings Top on Stable Volumes, Shares Up 7.4%
by Zacks Equity Research
Pediatrix's (MD) second-quarter earnings benefit from stable patient volumes. Rising expenses act as a partial offset.
Is Athira Pharma (ATHA) Stock Outpacing Its Medical Peers This Year?
by Zacks Equity Research
Here is how Athira Pharma, Inc. (ATHA) and HCA Healthcare (HCA) have performed compared to their sector so far this year.
Select Medical's (SEM) Stock Down 16.9% Despite Q2 Earnings Beat
by Zacks Equity Research
Select Medical (SEM) expects its adjusted EBITDA between $845 million and $885 million for 2024, the mid-point of which implies a 7.1% rise from the 2023 reported figure of $807.4 million.
National Fuel Gas and Landstar System Industries have been highlighted as Zacks Bull and Bear of the Day
by Zacks Equity Research
National Fuel Gas and Landstar System Industries have been highlighted as Zacks Bull and Bear of the Day
3 Sector ETFs & Stocks to Bet on July Jobs Data
by Sanghamitra Saha
The US economy added 114,000 jobs in July 2024, well below a downwardly revised 179,000 in June and forecasts of 175,000.
Global Week Ahead: Nervous Stock Markets
by John Blank
Earnings season has been pretty solid so far, but that's not enough to calm jittery investors who are concerned about a recession that still appears unlikely. So get ready for another volatile week.
Earnings Growth & Price Strength Make HCA Healthcare (HCA) a Stock to Watch
by Zacks Equity Research
The Zacks Focus List offers investors a way to easily find top-rated stocks and build a winning investment portfolio. Here's why you should take advantage.
Teladoc Health (TDOC) Shares Down 8.9% Despite Q2 Earnings Beat
by Zacks Equity Research
Teladoc Health (TDOC) expects revenue growth in the Integrated Care segment to be within low to mid-single-digit growth in 2024, on a year-over-year basis.
Zacks.com featured highlights include HCA Healthcare, Taiwan Semiconductor Manufacturing, H&R Block, Leidos and The TJX Companies
by Zacks Equity Research
HCA Healthcare, Taiwan Semiconductor Manufacturing, H&R Block, Leidos and The TJX Companies are part of the Zacks Screen of the Week article.
ETFs & Stocks in Focus on Kamala Harris' Shift in Strategy
by Sanghamitra Saha
Analysts have noticed that Harris's 2024 campaign for president is a bit different than what it was in 2024, as quoted on yahoo finance.
Cigna (CI) Q2 Earnings Top on Specialty Business Strength
by Zacks Equity Research
Cigna's (CI) Q2 results reflect new client wins in the Evernorth Health Services unit, partly offset by elevated pharmacy costs. It continues to expect adjusted EPS of at least $28.40 for 2024.
5 Top-Ranked Dividend Stocks for Growth of Your Portfolio
by Sweta Killa
HCA Healthcare (HCA), Taiwan Semiconductor (TSM), H&R Block (HRB), Leidos Holdings. (LDOS) and The TJX Companies (TJX) could be solid choices for your portfolio.
Q2 Boost for Tenet (THC): A Healthy Dose of Long-Term Gains
by Kaibalya Pravo Dey
Tenet (THC) shares jump 8.3% since Q2 earnings beat, as investors grow increasingly confident about the company's future prospects.
Why HCA Healthcare (HCA) is a Top Growth Stock for the Long-Term
by Zacks Equity Research
The Zacks Style Scores offers investors a way to easily find top-rated stocks based on their investing style. Here's why you should take advantage.
Ensign Group (ENSG) Q2 Earnings Beat on Occupancy, Stock Up 7.2%
by Zacks Equity Research
Ensign Group's (ENSG) second-quarter results benefit from improved occupancy and skilled services revenue. Higher expenses partially offset the results.
Zacks.com featured highlights HCA Healthcare, CrediCorp, Booz Allen Hamilton and Hubbell
by Zacks Equity Research
HCA Healthcare, CrediCorp, Booz Allen Hamilton and Hubbell have been highlighted in this Screen of The Week article.
Scoop up These 4 GARP Stocks to Receive Handsome Returns
by Zacks Equity Research
The GARP strategy helps investors gain exposure to stocks that have impressive prospects and are trading at a discount. HCA, BAP, BAH and HUBB are some stocks that hold promise.
Why HCA Healthcare (HCA) is a Top Value Stock for the Long-Term
by Zacks Equity Research
Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores.
Here's How Much a $1000 Investment in HCA Healthcare Made 10 Years Ago Would Be Worth Today
by Zacks Equity Research
Why investing for the long run, especially if you buy certain popular stocks, could reap huge rewards.